PER 1.41% 7.0¢ percheron therapeutics limited

Ann: US FDA Type C Meeting for ATL1102 in DMD, page-86

  1. 1,703 Posts.
    lightbulb Created with Sketch. 605
    Seriously?- The company only needs to communicate with shareholders when there is a need to - either a disclosure obligation or a newsworthy event. I know I would rather have the company concentrating on doing the business & improving the value of my investment rather than soothing nervous nellies who maybe doubting their own investment thesis. Sit back & await the news-flow.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
-0.001(1.41%)
Mkt cap ! $63.10M
Open High Low Value Volume
7.1¢ 7.1¢ 6.9¢ $34.01K 486.5K

Buyers (Bids)

No. Vol. Price($)
2 132919 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 78000 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.